Background N-terminal pro-hormone B-type natriuretic peptide (NT-proBNP) levels correlate
with higher peri-procedural mortality after transcatheter aortic valve replacement (TAVR) …

Little is known about the usefulness of evaluating cardiac neurohormones in patients
undergoing transcatheter aortic valve implantation (TAVI). The objectives of this study were …

Background Limited data on the prognostic value of periprocedural changes of plasma N-
terminal pro-B-type natriuretic peptide (NT-proBNP) after transcatheter aortic valve …

Background Blood levels of N-terminal pro-B-type natriuretic peptide (NT-proBNP) has been
suggested as a future guidance tool for the selection of patients for aortic valve replacement …

Objectives We studied the prognostic value of plasma N‐terminal pro‐brain natriuretic
peptide (NT‐proBNP)‐ratio, which is independent of individual cutoff levels, in predicting …

Aims: We sought to define the predictive value and evolution of N‐terminal pro‐B‐type
natriuretic peptide (NT‐proBNP) levels following transcutaneous aortic valve implantation …

N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels prior to transcatheter aortic
valve implantation (TAVI) are known to be associated with outcomes of patients undergoing …

Background Unlike N-terminal pro-B-type natriuretic peptide (NT-proBNP), which have been
extensively studied, little is known about the role of N-terminal pro-C-type natriuretic peptide …

Background Biomarkers may significantly improve risk stratification algorithms for patients
undergoing transcatheter aortic valve implantation (TAVI). While N-terminal pro-B-type …

Background Cardiovascular biomarkers constitute promising tools for improved risk
stratification and prediction of outcome in patients undergoing transcatheter aortic valve …